🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer laws, risking fines, legal action or prison.

Service Response and Content Removal

Based on TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company said it was committed to keeping the service safe and investing in strengthening compliance measures.

Online Marketplace Operations

Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.

After moments of entering one community, a seller posted WhatsApp details, where most transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about body mass, health issues or past usage.

Product Details and Costs

Within these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has already seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to possibly serious health risks”.